
Fee-Way Pharmaceuticals Private Limited
About Fee-Way Pharmaceuticals Private Limited
Data last updated:
Fee-Way Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2021PTC155278.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Kumar Sharma and Rohit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Faryad S/O Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.87 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹14,089 (net margin -4.9%) and EBITDA of -₹13,440 (EBITDA margin -4.7%).
Company details
Contact details
Fee-Way Pharmaceuticals Private Limited's registered office is in Bareilly, Uttar Pradesh.
- Registered AddressC/O Faryad S/O Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fee-Way Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fee-Way Pharmaceuticals Private Limited, buy the company report.
Financials of Fee-Way Pharmaceuticals Private Limited
FY 2024 filings availableFee-Way Pharmaceuticals Private Limited reported revenue of ₹2.87 Lakh (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year. EBITDA rose 79% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹13,440 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹14,089 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -4.7% | ||
| Net Profit Margin | -4.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Fee-Way Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fee-Way Pharmaceuticals Private Limited
Fee-Way Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar Sharma | Director | 09 Nov 2023 | 3 Years 0 Months | Current |
| Rohit Sharma | Director | 11 Nov 2021 | 5 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Fee-Way Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fee-Way Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Fee-Way Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Fee-Way Pharmaceuticals Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Mohd Irfan Ansari ceased to be Director on 09 Nov 2023.
Frequently asked questions
Fee-Way Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 November 2021 (5+ years old) and is registered under CIN U24299UP2021PTC155278.
Fee-Way Pharmaceuticals has 2 current directors:
- Rajeev Kumar Sharma - Director
- Rohit Sharma - Director
The latest financial statements of Fee-Way Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Fee-Way Pharmaceuticals is U24299UP2021PTC155278. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fee-Way Pharmaceuticals was incorporated on 11 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Mohd Irfan Ansari ceased to be Director on 09 Nov 2023. Mohd Shoaib ceased to be Director on 09 Nov 2023. Rajeev Kumar Sharma was appointed as Director on 09 Nov 2023. Fee-Way Pharmaceuticals has 4 board changes on record in total.
The registered office of Fee-Way Pharmaceuticals is at CO Faryad SO Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123.
Fee-Way Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Fee-Way Pharmaceuticals can be reached at its registered office: CO Faryad SO Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123.
Fee-Way Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.

